尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the detailed record of transactions filed by Friedberg Ezra M. Officer active across 2 companies, notably Chromocell Therapeutics Corp. Cumulatively, 10 filings have been logged. Split: 1 buy · 4 sells. Total volume traded: €115k. Activity tracked since 21 February 2024. The latest transaction was disclosed on 2 July 2026 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 条申报中的 10 条
Friedberg Ezra M is a declarant linked to Pelthos Therapeutics Inc. and Chromocell Therapeutics Corp, where he is a Director. The 6 filings in the recent sampled set cover the period from 2024-02-23 to 2026-07-07, with EUR 92482 in purchases and EUR 22855 in sales; the most frequent transaction nature is Cession.